Table 5.
Risk Factors Associated of PH in patients with different COPD stages.
Stage II, moderate | p | Stage III, severe | p | Stage IV, very severe | p | |
---|---|---|---|---|---|---|
FEV1, % (L/s) | 1,53 (1,29- 1,83) | 0,000 | 1,06(,99-1,12) | 0,05 | 1,20(1,05-1,36) | 0,005 |
FVC, % (L) | 0,85 (0,77-0,94) | 0,001 | 0,98(0,95-1,02) | 0,4 | 1,12(1,05-1,19) | 0,000 |
PaO2, mm Hg | 0,89 (0,79-0,99) | 0,04 | 1,04(1,01-1,07) | 0,001 | 1,031(,98-1,07) | 0,1 |
PaCO2, mm Hg | 1,07 (1,01- 1,13) | 0,02 | 1,02(1,00-1,05) | 0,02 | 1,02 (0,97-1,07) | 0,2 |
Age | 0,92(0,84-1,00) | 0,06 | 1,02(0,99-1,04) | 0,07 | 0,96 (0,93-1,00) | 0,07 |
sex | 29 (6-128) | 0,000 | 0,71 (0,36-1,34) | 0,3 | 7 (2-24) | 0,002 |